Nuclear power promises clean energy for developing countries. Dave Elliott charts its progress and prospects after the accident at Fukushima.

The recent nuclear scare in Japan has reinforced pressure in China to raise its awareness of the risks of new technologies. Li Jiao reports.

Developing countries need more women scientists. Jeanne Therese H. Andres charts the obstacles and how to overcome them.

Priya Shetty explores the tools and partnerships that help the public health community counter the threat of counterfeit medicines.

A dispute over the HINARI scheme, which gives poor countries free journal access, has exposed the sensitive border between aid and commerce, finds Yojana Sharma.

Mohamed Hassan, outgoing executive director of TWAS, talks to SciDev.Net about 25 years in the job and his hopes for the academy's future.

Can developing countries use nanotechnology to improve health? Priya Shetty looks at nanomedicine's promise.

All it takes is a roof, a gutter and a tank to lift the poor out of water drudgery. But is it that simple, ask Aisling Irwin and Aditya Ghosh?

Traditional and modern medicine have much to offer each other despite their differences. Priya Shetty assesses an uneasy relationship.

Hindu-Kush-Himalayan countries need to share data and collaborate better to tackle climate change, Andreas Schild tells SciDev.Net.

Many new technologies have promised to remove arsenic from drinking water but little has changed on the ground, finds T. V. Padma.

Developing nations are building their own satellites despite freely available Western data. Do the gains outweigh the costs, asks Tatum Anderson.

Priya Shetty explains the links between climate change and insect-borne disease, and outlines priorities for developing country policymakers.

China's profitable rubber industry is a boon for some rural communities, but the environmental costs could be much higher.

Yvo de Boer, the UN climate chief, speaks to SciDev.Net about getting clean technology into the developing world.

Opinions on China's recent US$3.7 billion GM roll-out remain divided, with concerns over potential risks and regulation loopholes.

Developing countries are attractive places to run clinical trials, but in many places ethical oversight falls short.

Science must take the lead role in economic development, says Chinese premier Wen Jiabao.

Big pharma drug companies are striking deals with Asian drug researchers to secure the future of the drug industry.

Trials of a vaccine to prevent nasopharyngeal cancer will start soon in China, where it mainly affects the Cantonese-speaking population.